PATENT CLAIM ANALYSIS

Application Number: 15945901
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "179000"]

Abstract:
A method that includes testing for the presence of a phosphorylated Ser294 (phospho-Ser294) progesterone receptor (PR). A method that includes determining the expression level of a gene in a patient sample and comparing it to a control sample.

Claim (Index 3):
The method of  claim 1 , wherein the patient has been diagnosed with a breast cancer.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 91.0
- Lexical Diversity: 1.41935
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13843482', '14363551', '14296127', '10342887', '12214878']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.779785500534941
- 35 USC 102 Novelty (BERT): 0.56545519975376
- Combined Prediction Score: 0.758352470456823
- Mean Citation Score: 321.14236199999993
- Max Citation Score: 453.25696
- Similarity Product: 371.64317442977904

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test